Why is Biogen Pharma falling/rising?

As of 10-Sep, Biogen Pharmachem Industries Ltd is experiencing a decline in its stock price, currently at 0.88, reflecting a decrease of 0.01 or 1.12%. The stock has underperformed its sector by 0.73% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 3.30%, and its year-to-date performance shows a significant drop of 25.42%. Although there has been a rise in investor participation with a delivery volume increase of 4.96% against the 5-day average, the overall trend remains negative, and there are no positive or negative factors provided to further explain the stock's recent movement.
In the broader market context, Biogen Pharma's short-term performance has been notably poor compared to the benchmark, with the Sensex gaining 1.06% over the past week while Biogen has lost 3.30%. This underperformance is consistent with its longer-term returns, where the stock has decreased by 33.33% over the past year, contrasting sharply with the Sensex's slight decline of 0.61%. The stark difference in performance indicates that investor sentiment towards Biogen Pharma is weak, especially in comparison to the broader market, which has shown resilience.